Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Review

Non-Coding Loss-of-Function Variation in Human Genomes

Zappala Z.a · Montgomery S.B.a, b

Author affiliations

Departments of aGenetics and bPathology, Stanford University, Stanford, Calif., USA

Related Articles for ""

Hum Hered 2016;81:78-87

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Review

Published online: January 12, 2017
Issue release date: January 2017

Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 3

ISSN: 0001-5652 (Print)
eISSN: 1423-0062 (Online)

For additional information: https://www.karger.com/HHE

Abstract

Whole-genome and exome sequencing in human populations has revealed the tolerance of each gene for loss-of-function variation. By understanding this tolerance, it has become increasingly possible to identify genes that would make safe therapeutic targets and to identify rare genetic risk factors and phenotypes at the scale of individual genomes. To date, the vast majority of surveyed loss-of-function variants are in protein-coding regions of the genome mainly due to the focus on these regions by exome-based sequencing projects and their relative ease of interpretability. As whole-genome sequencing becomes more prevalent, new strategies will be required to uncover impactful variation in non-coding regions of the genome where the architecture of genome function is more complex. In this review, we investigate recent studies of loss-of-function variation and emerging approaches for interpreting whole-genome sequencing data to identify rare and impactful non-coding loss-of-function variants.

© 2017 S. Karger AG, Basel


References

  1. Keinan A, Clark AG: Recent explosive human population growth has resulted in an excess of rare genetic variants. Science 2012;336:740-743.
  2. 1000 Genomes Project Consortium; Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al: A global reference for human genetic variation. Nature 2015;526:68-74.
  3. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, et al: Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010;42:790-793.
  4. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, et al: Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010;42:30-35.
  5. Hoischen A, van Bon BWM, Gilissen C, Arts P, van Lier B, Steehouwer M, et al: De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 2010;42:483-485.
  6. Singh T, Kurki MI, Curtis D, Purcell SM, Crooks L, McRae J, et al: Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat Neurosci 2016;19:571-577.
  7. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, Zhang CK, et al: Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011;43:1066-1073.
  8. Chen R, Shi L, Hakenberg J, Naughton B, Sklar P, Zhang J, et al: Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases. Nat Biotechnol 2016;34:531-538.
  9. Nelson MR, Wegmann D, Ehm MG, Kessner D, St Jean P, Verzilli C, et al: An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science 2012;337:100-104.
  10. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, et al: Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012;337:64-69.
  11. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, et al: A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012;335:823-828.
  12. Lim ET, Würtz P, Havulinna AS, Palta P, Tukiainen T, Rehnström K, et al: Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet 2014;10:e1004494.
  13. Narasimhan VM, Hunt KA, Mason D, Baker CL, Karczewski KJ, Barnes MR, et al: Health and population effects of rare gene knockouts in adult humans with related parents. Science 2016;aac8624.
  14. Saleheen D, Natarajan P, Zhao W, Rasheed A, Khetarpal S, Won HH, et al: Human knockouts in a cohort with a high rate of consanguinity. bioRxiv, 2015, DOI: 10.1101/031518.
  15. Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T, et al: Analysis of protein-coding genetic variation in 60,706 humans. bioRxiv, 2015, DOI: 10.1101/030338.
  16. MacArthur DG, Tyler-Smith C: Loss-of-function variants in the genomes of healthy humans. Hum Mol Genet 2010;19:R125-R130.
  17. Kukurba KR, Zhang R, Li X, Smith KS, Knowles DA, How Tan M, et al: Allelic expression of deleterious protein-coding variants across human tissues. PLoS Genet 2014;10:e1004304.
  18. Lappalainen T, Sammeth M, Friedländer MR, ‘t Hoen PAC, Monlong J, Rivas MA, et al: Transcriptome and genome sequencing uncovers functional variation in humans. Nature 2013;501:506-511.
  19. Rivas MA, Pirinen M, Conrad DF, Lek M, Tsang EK, Karczewski KJ, et al: Human genomics. Effect of predicted protein-truncating genetic variants on the human transcriptome. Science 2015;348:666-669.
  20. Roach JC, Glusman G, Smit AFA, Huff CD, Hubley R, Shannon PT, et al: Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 2010;328:636-639.
  21. Li X, Montgomery SB: Detection and impact of rare regulatory variants in human disease. Front Genet 2013;4:67.
  22. Makrythanasis P, Antonarakis SE: Pathogenic variants in non-protein-coding sequences. Clin Genet 2013;84:422-428.
  23. Ma M, Ru Y, Chuang L-S, Hsu N-Y, Shi L-S, Hakenberg J, et al: Disease-associated variants in different categories of disease located in distinct regulatory elements. BMC Genomics 2015;16(suppl 8):S3.
  24. Daneshjou R, Zappala Z, Kukurba K, Boyle SM, Ormond KE, Klein TE, et al: Path-scan: a reporting tool for identifying clinically actionable variants. Pac Symp Biocomput 2014;229-240.
  25. Van Schil K, Karlstetter M, Aslanidis A, Dannhausen K, Azam M, Qamar R, et al: Autosomal recessive retinitis pigmentosa with homozygous rhodopsin mutation E150K and non-coding cis-regulatory variants in CRX-binding regions of SAMD7. Sci Rep 2016;6:21307.
  26. Nellist M, Brouwer RWW, Kockx CEM, van Veghel-Plandsoen M, Withagen-Hermans C, Prins-Bakker L, et al: Targeted next generation sequencing reveals previously unidentified TSC1 and TSC2 mutations. BMC Med Genet 2015;16:10.
  27. Lin Y, Lin S, Baxter MD, Lin L, Kennedy SM, Zhang Z, et al: Novel APC promoter and exon 1B deletion and allelic silencing in three mutation-negative classic familial adenomatous polyposis families. Genome Med 2015;7:42.
  28. Davidson AE, Liskova P, Evans CJ, Dudakova L, Nosková L, Pontikos N, et al: Autosomal-dominant corneal endothelial dystrophies CHED1 and PPCD1 are allelic disorders caused by non-coding mutations in the promoter of OVOL2. Am J Hum Genet 2016;98:75-89.
  29. Giorgio E, Robyr D, Spielmann M, Ferrero E, Di Gregorio E, Imperiale D, et al: A large genomic deletion leads to enhancer adoption by the lamin B1 gene: a second path to autosomal dominant adult-onset demyelinating leukodystrophy (ADLD). Hum Mol Genet 2015;24:3143-3154.
  30. Melnikov A, Murugan A, Zhang X, Tesileanu T, Wang L, Rogov P, et al: Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat Biotechnol 2012;30:271-277.
  31. Patwardhan RP, Lee C, Litvin O, Young DL, Pe'er D, Shendure J: High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis. Nat Biotechnol 2009;27:1173-1175.
  32. Kwasnieski JC, Mogno I, Myers CA, Corbo JC, Cohen BA: Complex effects of nucleotide variants in a mammalian cis-regulatory element. Proc Natl Acad Sci USA 2012;109:19498-19503.
  33. Vockley CM, Guo C, Majoros WH, Nodzenski M, Scholtens DM, Hayes MG, et al: Massively parallel quantification of the regulatory effects of noncoding genetic variation in a human cohort. Genome Res 2015;25:1206-1214.
  34. Jordan DM, Frangakis SG, Golzio C, Cassa CA, Kurtzberg J; Task Force for Neonatal Genomics, et al: Identification of cis-suppression of human disease mutations by comparative genomics. Nature 2015;524:225-229.
  35. Albers CA, Paul DS, Schulze H, Freson K, Stephens JC, Smethurst PA, et al: Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet 2012;44:435-439-S1-S2.
  36. Wieczorek D, Newman WG, Wieland T, Berulava T, Kaffe M, Falkenstein D, et al: Compound heterozygosity of low-frequency promoter deletions and rare loss-of-function mutations in TXNL4A causes Burn- McKeown syndrome. Am J Hum Genet 2014;95:698-707.
  37. Montgomery SB, Lappalainen T, Gutierrez-Arcelus M, Dermitzakis ET: Rare and common regulatory variation in population-scale sequenced human genomes. PLoS Genet 2011;7:e1002144.
  38. Lappalainen T, Montgomery SB, Nica AC, Dermitzakis ET: Epistatic selection between coding and regulatory variation in human evolution and disease. Am J Hum Genet 2011;89:459-463.
  39. Nagasaki M, Yasuda J, Katsuoka F, Nariai N, Kojima K, Kawai Y, et al: Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals. Nat Commun 2015;6:8018.
  40. Sidore C, Busonero F, Maschio A, Porcu E, Naitza S, Zoledziewska M, et al: Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat Genet 2015;47:1272-1281.
  41. Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Oddson A, Gylfason A, et al: Large-scale whole-genome sequencing of the Icelandic population. Nat Genet 2015;47:435-444.
  42. UK10K Consortium; Walter K, Min JL, Huang J, Crooks L, Memari Y, et al: The UK10K project identifies rare variants in health and disease. Nature 2015;526:82-90.
  43. Ng PC, Henikoff S: SIFT: Predicting amino acid changes that affect protein function. Nucl Acids Res 2003;31:3812-3814.
  44. Adzhubei I, Jordan DM, Sunyaev SR: Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 2013;76:7.20:7.20-7.20.41.
  45. Li M-X, Gui H-S, Kwan JSH, Bao S-Y, Sham PC: A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases. Nucleic Acids Res 2012;40:e53-e53.
  46. Li M-X, Kwan JSH, Bao S-Y, Yang W, Ho S-L, Song Y-Q, et al: Predicting mendelian disease-causing non-synonymous single nucleotide variants in exome sequencing studies. PLoS Genet 2013;9:e1003143.
  47. Robinson PN, Köhler S, Oellrich A; Sanger Mouse Genetics Project, Wang K, Mungall CJ, et al: Improved exome prioritization of disease genes through cross-species phenotype comparison. Genome Res 2014;24:340-348.
  48. Veyrieras J-B, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M, et al: High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008;4:e1000214.
  49. Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, et al: Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013;45:1238-1243.
  50. Claussnitzer M, Dankel SN, Kim K-H, Quon G, Meuleman W, Haugen C, et al: FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 2015;373:895-907.
  51. Flavahan WA, Drier Y, Liau BB, Gillespie SM, Venteicher AS, Stemmer-Rachamimov AO, et al: Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 2016;529:110-114.
  52. Lee MN, Ye C, Villani AC, Raj T, Li W, Eisenhaure TM, et al: Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science 2014;343:1246980.
  53. GTEx Consortium: Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015;348:648-660.
  54. Spies N, Smith CL, Rodriguez JM, Baker JC, Batzoglou S, Sidow A: Constraint and divergence of global gene expression in the mammalian embryo. Elife 2015;4:e05538.
  55. Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A: Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 2010;20:110-121.
  56. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, et al: Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005;15:1034-1050.
  57. Cooper GM, Stone EA, Asimenos G; NISC Comparative Sequencing Program, Green ED, Batzoglou S, et al: Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 2005;15:901-913.
  58. ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, et al: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007;447:799-816.
  59. ENCODE Project Consortium: An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
  60. Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, et al: Integrative analysis of 111 reference human epigenomes. Nature 2015;518:317-330.
  61. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J: A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014;46:310-315.
  62. Ritchie GRS, Dunham I, Zeggini E, Flicek P: Functional annotation of noncoding sequence variants. Nat Methods 2014;11:294-296.
  63. Gulko B, Hubisz MJ, Gronau I, Siepel A: A method for calculating probabilities of fitness consequences for point mutations across the human genome. Nat Genet 2015;47:276-283.
  64. Lee D, Gorkin DU, Baker M, Strober BJ, Asoni AL, McCallion AS, et al: A method to predict the impact of regulatory variants from DNA sequence. Nat Genet 2015;47:955-961.
  65. Montgomery SB, Sammeth M, Gutierrez- Arcelus M, Lach RP, Ingle C, Nisbett J, et al: Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 2010;464:773-777.
  66. Pickrell JK, Marioni JC, Pai AA, Degner JF, Engelhardt BE, Nkadori E, et al: Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 2010;464:768-772.
  67. Stranger BE, Montgomery SB, Dimas AS, Parts L, Stegle O, Ingle CE, et al: Patterns of cis regulatory variation in diverse human populations. PLoS Genet 2012;8:e1002639.
  68. Battle A, Mostafavi S, Zhu X, Potash JB, Weissman MM, McCormick C, et al: Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res 2014;24:14-24.
  69. Lee MN, Ye C, Villani AC, Raj T, Li W, Eisenhaure TM, et al: Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science 2014;343:1246980.
  70. Fairfax BP, Humburg P, Makino S, Naranbhai V, Wong D, Lau E, et al: Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 2014;343:1246949.
  71. Li X, Battle A, Karczewski KJ, Zappala Z, Knowles DA, Smith KS, et al: Transcriptome sequencing of a large human family identifies the impact of rare noncoding variants. Am J Hum Genet 2014;95:245-256.
  72. Zeng Y, Wang G, Yang E, Ji G, Brinkmeyer-Langford CL, Cai JJ: Aberrant gene expression in humans. PLoS Genet 2015;11: e1004942.
  73. Guan J, Yang E, Yang J, Wang G, Zeng Y, Ji G, et al: Aberrant gene expression in autism. bioRxiv, 2015, DOI: 10.1101/029488.
  74. Duan J, Sanders AR, Moy W, Drigalenko EI, Brown EC, Freda J, et al: Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants. Hum Mol Genet 2015;ddv199.
  75. Zhao J, Akinsanmi I, Arafat D, Cradick TJ, Lee CM, Banskota S, et al: A burden of rare variants associated with extremes of gene expression in human peripheral blood. Am J Hum Genet 2016;98:299-309.
  76. Gonorazky H, Liang M, Cummings B, Lek M, Micallef J, Hawkins C, et al: RNAseq analysis for the diagnosis of muscular dystrophy. Ann Clin Transl Neurol 2016;3:55-60.
  77. Zhang H, Xue C, Shah R, Bermingham K, Hinkle CC, Li W, et al: Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease. Circ Res 2015;117: 17-28.

Article / Publication Details

First-Page Preview
Abstract of Review

Published online: January 12, 2017
Issue release date: January 2017

Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 3

ISSN: 0001-5652 (Print)
eISSN: 1423-0062 (Online)

For additional information: https://www.karger.com/HHE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.